Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5288334
Max Phase: Preclinical
Molecular Formula: C41H41N3O8S2
Molecular Weight: 767.93
Associated Items:
ID: ALA5288334
Max Phase: Preclinical
Molecular Formula: C41H41N3O8S2
Molecular Weight: 767.93
Associated Items:
Canonical SMILES: O=C(Cc1ccc2c(c1)OCO2)N[C@@H](Cc1ccccc1)C(=O)N[C@H](/C=C/S(=O)(=O)c1ccccc1)CCCCNS(=O)(=O)c1cccc2ccccc12
Standard InChI: InChI=1S/C41H41N3O8S2/c45-40(28-31-21-22-37-38(27-31)52-29-51-37)44-36(26-30-12-3-1-4-13-30)41(46)43-33(23-25-53(47,48)34-17-5-2-6-18-34)16-9-10-24-42-54(49,50)39-20-11-15-32-14-7-8-19-35(32)39/h1-8,11-15,17-23,25,27,33,36,42H,9-10,16,24,26,28-29H2,(H,43,46)(H,44,45)/b25-23+/t33-,36-/m0/s1
Standard InChI Key: CUKJSVPHTFYYTM-HMJRBNEZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 767.93 | Molecular Weight (Monoisotopic): 767.2335 | AlogP: 5.46 | #Rotatable Bonds: 17 |
Polar Surface Area: 156.97 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.92 | CX Basic pKa: | CX LogP: 5.64 | CX LogD: 5.64 |
Aromatic Rings: 5 | Heavy Atoms: 54 | QED Weighted: 0.11 | Np Likeness Score: -0.44 |
1. Doherty W, Adler N, Butler TJ, Knox AJS, Evans P.. (2020) Synthesis and optimisation of P3 substituted vinyl sulfone-based inhibitors as anti-trypanosomal agents., 28 (23.0): [PMID:32992251] [10.1016/j.bmc.2020.115774] |
Source(1):